Jennifer R. O'Connor, Stuart Johnson, Dale N. Gerding  Gastroenterology 

Slides:



Advertisements
Similar presentations
MyD88 Signaling in the Intestine: Dr Jekyll and Mr Hyde?
Advertisements

Investigation of Outbreak of Infections Caused by Salmonella Saintpaul
Volume 132, Issue 3, Pages (March 2007)
Christoph Lübbert, Babett Holler  Gastroenterology 
c-Kit as a Novel Potential Therapeutic Target in Colorectal Cancer
Evaluation and Management of End-Stage Liver Disease in Children
James E. Everhart, Constance E. Ruhl  Gastroenterology 
Is Hepatitis C Virus Carcinogenic?
Effectiveness of Hepatitis B Treatment in Clinical Practice
Is HCV Infection a Neurologic Disorder?
Outcomes Among Living Liver Donors
David L. McCollum, J. Martin Rodriguez 
Defensins Versus Bacteria: Not Just Antibiotics Anymore
Clostridium difficile Infection and the Tangled Web of Interactions Among Host, Pathogen, and Microbiota  Anna Maria Seekatz, Vincent Bensan Young  Gastroenterology 
Investigation of Outbreak of Infections Caused by Salmonella Saintpaul
The Increasing Diversity of KRAS Signaling in Pancreatic Cancer
New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to.
Clinical Challenges and Images in GI
Volume 155, Issue 4, Pages (October 2018)
Volume 135, Issue 4, Pages (October 2008)
A Historical Perspective on Clinical Advances in Pancreatic Diseases
Volume 150, Issue 4, Pages (April 2016)
The Bone Marrow and Liver Fibrosis: Friend or Foe?
Jean-Michel Pawlotsky  Gastroenterology 
Shrikant Anant, Courtney W. Houchen  Gastroenterology 
Volume 133, Issue 6, Pages (December 2007)
Jeffrey Cloud, Laura Noddin, Amanda Pressman, Mary Hu, Ciaran Kelly 
Circadian Clock Control of Liver Metabolic Functions
The Cell Biology of the Unfolded Protein Response
Are Proton Pump Inhibitors Affecting Intestinal Microbiota Health?
HMGA2, MicroRNAs, and Stem Cell Aging
Volume 145, Issue 1, Pages (July 2013)
Singling Out Intestinal Epithelial Stem Cells
MyD88 Signaling in the Intestine: Dr Jekyll and Mr Hyde?
Burden of Digestive Diseases in the United States Part I: Overall and Upper Gastrointestinal Diseases  James E. Everhart, Constance E. Ruhl  Gastroenterology 
Treatment of Clostridium difficile-Associated Disease
Targeting Smads to Restore Transforming Growth Factor-β Signaling and Regulatory T- Cell Function in Inflammatory Bowel Disease  Deanna D. Nguyen, Scott.
Colin Crooks, Tim Card, Joe West  Gastroenterology 
Coffee and Colorectal Cancer: Grounds for Prevention?
Reduced Mortality Rates Following Elective Percutaneous Liver Biopsies
This Month in Gastroenterology
Amnon Sonnenberg  Clinical Gastroenterology and Hepatology 
Time Trends of Ulcer Mortality in Europe
Constance E. Ruhl, James E. Everhart  Gastroenterology 
Raina Shivashankar, Sahil Khanna, Patricia P. Kammer, W
Ashwin N. Ananthakrishnan, David Lieberman  Gastroenterology 
Volume 148, Issue 3, Pages (March 2015)
E.J. Kuijper, B. Coignard, P. Tüll  Clinical Microbiology and Infection 
Shivan J. Mehta, Kimberly A. Forde  Gastroenterology 
Caitlin C. Murphy, Kristin Wallace, Robert S. Sandler, John A. Baron 
Covering the Cover Gastroenterology
Decreasing Mortality Among Patients Hospitalized With Cirrhosis in the United States From 2002 Through 2010  Monica L. Schmidt, A. Sidney Barritt, Eric.
The Dawning of a New Editorial Board for Gastroenterology
Raffaele Pezzilli, MD, Giulio Cariani, MD  Gastroenterology 
Volume 132, Issue 3, Pages (March 2007)
Volume 151, Issue 4, Pages (October 2016)
Volume 56, Issue 4, Pages (October 1999)
Changing of the Guards: 2011–2016 Gastroenterology Team
Volume 156, Issue 4, Pages (March 2019)
Volume 155, Issue 6, Pages (December 2018)
Volume 139, Issue 6, Pages e1 (December 2010)
Cancer Costs Projected to Reach at Least $158 Billion in 2020
Volume 138, Issue 6, Pages (May 2010)
End-Stage Liver Disease in 2008: Finally a Glass Half Full
Reinvesting in US Biomedical Research—The Time is Now
Volume 119, Issue 4, Pages (October 2000)
Electronic Clinical Challenges and Images in GI
The Future of Endoscopic Retrograde Cholangiopancreatography
Controversies in Liver Transplantation for Hepatitis C
Volume 153, Issue 5, Pages (November 2017)
Presentation transcript:

Clostridium difficile Infection Caused by the Epidemic BI/NAP1/027 Strain  Jennifer R. O'Connor, Stuart Johnson, Dale N. Gerding  Gastroenterology  Volume 136, Issue 6, Pages 1913-1924 (May 2009) DOI: 10.1053/j.gastro.2009.02.073 Copyright © 2009 AGA Institute Terms and Conditions

Figure 1 Extent of BI/NAP1/027 distribution. (A) States in the United States that have had ≥1 hospital that has reported CDI caused by the BI/NAP1/027 epidemic strain as of October 2008 (red).116 (B) Percentage of C difficile isolates in Canadian provinces (no data are available for territories) with the BI/NAP1/027 strain in the 2005 Canadian Nosocomial Infection Surveillance Program (CNISP) survey.97 (C) Hospitals in Europe reporting outbreaks (stars) and sporadic cases (circles) of CDI caused by the BI/NAP1/027 strain.89 Gastroenterology 2009 136, 1913-1924DOI: (10.1053/j.gastro.2009.02.073) Copyright © 2009 AGA Institute Terms and Conditions

Figure 2 Frequency and mortality of CDI. (A) National estimates of US short-stay hospital discharges with C difficile infection as any listed diagnosis or the primary hospitalization diagnosis, based on the national inpatient sample117and unpublished data, 2008). (B) C difficile–related mortality based on listings on US death certificates from 1999 to 2004, with age-adjusted mortality rates per million people for the same years (shown in box).118 Gastroenterology 2009 136, 1913-1924DOI: (10.1053/j.gastro.2009.02.073) Copyright © 2009 AGA Institute Terms and Conditions

Figure 3 Model of regulation of toxin gene expression in C difficile. (A) Logarithmic growth phase. In logarithmic growth phase a single transcript encompassing tcdR, tcdB, and tcdA is expressed at a low level, most likely from a TcdR-independent promoter.25 In the presence of GTP and BCAAs, CodY binds to the TcdR-dependent tcdR promoter, PtcdR,21 which represses high-level expression of TcdR (required for high-level toxin expression22); thus, the toxin genes, tcdA and tcdB, are not optimally expressed. At this time the negative regulator gene, tcdC, is also maximally expressed.25 TcdC is a membrane-associated protein30 that most likely sequesters any small amount of TcdR that is expressed from the longer transcript,24 which further prevents expression of the toxin genes. (B) Stationary growth phase. Under nutrient limiting conditions or stress, such as in stationary phase, the toxin genes are highly expressed. In the absence of GTP and BCAA, CodY is unable to bind the TcdR-dependent tcdR promoter21; thus, it cannot repress tcdR expression. In addition, tcdC expression is minimal.25 TcdR is expressed and is free to interact with the RNA polymerase holoenzyme (RNAP).22,25 This complex can then bind to the tcdR promoter as well as to PtcdB and PtcdA to facilitate maximal expression of the tcdR, tcdA, and tcdB genes, resulting in production of toxins A and B.22 TcdE, a holin-like protein, is thought to facilitate release of toxins A and B from the C difficile cell.20 Gastroenterology 2009 136, 1913-1924DOI: (10.1053/j.gastro.2009.02.073) Copyright © 2009 AGA Institute Terms and Conditions

Jennifer R. O'Connor Gastroenterology 2009 136, 1913-1924DOI: (10.1053/j.gastro.2009.02.073) Copyright © 2009 AGA Institute Terms and Conditions

Stuart Johnson Gastroenterology 2009 136, 1913-1924DOI: (10.1053/j.gastro.2009.02.073) Copyright © 2009 AGA Institute Terms and Conditions

Dale N. Gerding Gastroenterology 2009 136, 1913-1924DOI: (10.1053/j.gastro.2009.02.073) Copyright © 2009 AGA Institute Terms and Conditions